Loading clinical trials...
Loading clinical trials...
Myotonic dystrophy (DM) and facioscapulohumeral muscular dystrophy (FSHD) are inherited disorders characterized by progressive muscle weakness and loss of muscle tissue. The purpose of this registry i...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Rochester
Collaborators
NCT05644522 · Cerebrovascular Accident, Post-polio Syndrome, and more
NCT07486934 · Myotonic Dystrophy Type 1 (DM1), DM1, and more
NCT06817382 · Duchenne Muscular Dystrophy
NCT06839469 · Spinal Muscular Atrophy Type 3, Duchenne Muscular Dystrophy (DMD)
NCT06907875 · Facioscapulohumeral Muscular Dystrophy
University of Rochester Medical Center, Department of Neurology
Rochester, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions